tiprankstipranks
Trending News
More News >
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
US Market

Cumberland Pharmaceuticals (CPIX) Financial Statements

Compare
226 Followers

Cumberland Pharmaceuticals Financial Overview

Cumberland Pharmaceuticals's market cap is currently $70.60M. The company's EPS TTM is $-0.13; its P/E ratio is -20.08; Cumberland Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 37.87M$ 39.55M$ 42.01M$ 35.99M$ 37.44M
Gross Profit$ 31.28M$ 33.49M$ 32.89M$ 27.17M$ 28.79M
Operating Income$ -6.43M$ -9.55M$ -5.70M$ -7.68M$ -6.38M
EBITDA$ 182.42K$ 2.49M$ 332.92K$ -857.83K$ -1.56M
Net Income$ -6.48M$ -6.28M$ -5.57M$ -3.51M$ -3.34M
Balance Sheet
Cash & Short-Term Investments$ 17.96M$ 18.32M$ 19.76M$ 27.04M$ 24.75M
Total Assets$ 75.58M$ 81.78M$ 92.93M$ 84.46M$ 96.46M
Total Debt$ 20.57M$ 18.43M$ 20.96M$ 16.06M$ 19.26M
Net Debt$ 2.61M$ 106.86K$ 1.20M$ -10.98M$ -5.49M
Total Liabilities$ 53.04M$ 52.52M$ 56.95M$ 41.86M$ 49.59M
Stockholders' Equity$ 22.85M$ 29.60M$ 36.27M$ 42.81M$ 46.99M
Cash Flow
Free Cash Flow$ -791.90K$ 5.64M$ 6.38M$ 5.99M$ 3.30M
Operating Cash Flow$ -612.19K$ 6.09M$ 8.45M$ 6.34M$ 5.42M
Investing Cash Flow$ 57.84K$ -105.69K$ -13.67M$ -501.89K$ -1.76M
Financing Cash Flow$ 196.90K$ -7.42M$ -2.06M$ -3.55M$ -7.12M
Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Cumberland Pharmaceuticals Debt to Assets

Cumberland Pharmaceuticals Cash Flow

Cumberland Pharmaceuticals Forecast EPS vs Actual EPS